The Vanderbilt Program for Next Generation Vaccines brings together scientists from the School of Medicine, the College of Arts & Science, and the School of Engineering who create a complex pipeline that integrates structural biology with big data for the discovery of novel antibodies that will spur the development of next-generation vaccines. The program reinvests into two of Vanderbilt’s core strengths that resulted from past investments – the Vanderbilt Vaccine Center (VVC) and the Center for Structural Biology (CSB) – in a new and innovative way.